Matches in Nanopublications for { ?s ?p "DDI between Ifosfamide and Etravirine - Ifosfamide, when administered concomitantly with etravirine (a strong CYP3A4 inducer), may experience an increase in the serum concentrations of its active metabolites. It is recommended to monitor for toxicity of ifosfamide therapy."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB01181_DB06414 title "DDI between Ifosfamide and Etravirine - Ifosfamide, when administered concomitantly with etravirine (a strong CYP3A4 inducer), may experience an increase in the serum concentrations of its active metabolites. It is recommended to monitor for toxicity of ifosfamide therapy." assertion.